| Type of financial instrument | Name | ISIN code | Nature of transaction | Linked to a share option programme | Volume | Unit | Price per unit | Currency code | Transaction date | Trading venue |
|---|---|---|---|---|---|---|---|---|---|---|
| Share | NeuroVive Pharmaceutical AB | SE0002575340 | Acquisition | 44,901 | Quantity | 1.32 | SEK | 21/12/2018 | NASDAQ STOCKHOLM AB | |
| Share | NeuroVive Pharmaceutical AB | SE0002575340 | Acquisition | 73,000 | Quantity | 1.30 | SEK | 27/12/2018 | NASDAQ STOCKHOLM AB |
| Name | ISIN code | Nature of transaction | Transaction date | Trading venue | Volume | Weighted average price |
|---|---|---|---|---|---|---|
| NeuroVive Pharmaceutical AB | SE0002575340 | Acquisition | 21/12/2018 | NASDAQ STOCKHOLM AB | 44,901 (Quantity) | 1.32 SEK |
| NeuroVive Pharmaceutical AB | SE0002575340 | Acquisition | 27/12/2018 | NASDAQ STOCKHOLM AB | 73,000 (Quantity) | 1.30 SEK |
| Total: | 117,901 |